Okay. So I think I talked about a piece of that in my script. So currently, I think we expect about $40 million for the calendar year revenue, so roughly $40 million. And some of the system is going to be shipped in June, but the majority of the system is going to be shipped, I think, in September and December. So altogether, I think we are looking at roughly $40 million because we only have half of the year to run these products. So the number actually is due to the shipment schedules and is not a change in end demand. We continue to expect the demand for PIXALUX to increase further in fiscal 2021, right?So compared to a lot of global market disruption. Actually, this performance, $40 million, is a very good performance. So in short summary, I think the piece that is on track and on schedule, and we are quite happy with it. So that's PIXALUX and the next year will be bigger. And the AP, I think we are also quite confident. If you look at the AP, I think increasing the transistor density is very important, right? So most of them actually increased the transistor taking density at the wafer level by level. But AP actually increased taking density in transition level, then it's much more affordable and much more effective, right? So this actually are very favorable to our TCB and free chip. And we are aiming at high-performance logic, high bandwidth in memory and also next generation of imaging sensor.So AP, I think many players, and we are actually a little bit late, but we are quite confident. So we are in the process to gain the market shares, establish a good foundation. So to see AP getting much bigger, probably will be 2021. And we are quite confident 2022 will be much, much bigger. But we will see the sizable increase, I think, in 2021. So that's PIXALUX and AP. And the other one is the APS. I think we are much stronger in the APS, putting much focus. So we, hopefully, we will see from now to 2022, we can contribute probably close to $200 million in AP plus advanced LED and maybe additional $50 million for the APS.